Alliance Pharma PLC Notification of Major Holdings (6201A)
June 02 2021 - 7:56AM
UK Regulatory
TIDMAPH
RNS Number : 6201A
Alliance Pharma PLC
02 June 2021
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer
and to the FCA in Microsoft Word format if possible)
1a. Identity of the issuer or the Alliance Pharma plc
underlying issuer of existing shares
to which voting rights are attached
:
-------------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark
with an "X" if appropriate)
Non-UK issuer
----------------
2. Reason for the notification (please mark the appropriate box
or boxes with an "X")
An acquisition or disposal of voting rights X
----------------
An acquisition or disposal of financial instruments
----------------
An event changing the breakdown of voting rights
----------------
Other (please specify):
----------------
3. Details of person subject to the notification obligation
Name John Dawson (beneficial and non-beneficial
holdings)
City and country of registered
office (if applicable)
4. Full name of shareholder(s) (if different from 3.)
Name
-------------------------------------------------------------
City and country of registered
office (if applicable)
-------------------------------------------------------------
5. Date on which the threshold 28/05/2021
was crossed or reached :
-------------------------------------------------------------
6. Date on which issuer notified 01/06/2021
(DD/MM/YYYY):
-------------------------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting Total of both Total number of
rights attached rights through in % (8.A + voting rights
to shares (total financial instruments 8.B) of issuer
of 8. A) (total of 8.B
1 + 8.B 2)
----------------------- ------------------------ ----------------- ----------------
Resulting situation
on the date
on which threshold
was crossed
or reached 3.5% 0 3.5% 534,827,034
----------------------- ------------------------ ----------------- ----------------
Position of
previous notification
(if
applicable) 4.5% 0 4.5% 534,011,603
----------------------- ------------------------ ----------------- ----------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached
A: Voting rights attached to shares
Class/type Number of voting rights % of voting rights
of
shares
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of (Art 9 of Directive (Art 10 of
2004/109/EC) Directive 2004/109/EC) Directive
(DTR5.1) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.2.1) (DTR5.2.1)
------------------
Ordinary
GB0031030819 18,876,402 - 3.5% -
-------------------- ------------------ ---------------------------- -----------------
SUBTOTAL 8.
A 18,876,402 3.5%
---------------------------------------- -----------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive
2004/109/EC (DTR5.3.1.1 (a))
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
be acquired if
the instrument
is
exercised/converted.
-------------------- ------------------ ---------------------------- -----------------
SUBTOTAL 8. B
1
------------------ ---------------------------- -----------------
B 2: Financial Instruments with similar economic effect according
to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial Expiration Exercise/ Physical Number % of voting
instrument date Conversion or cash of voting rights
Period settlement rights
--------------------- ------------------ ------------ --------------
SUBTOTAL
8.B.2
------------ --------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any
other undertaking(s) holding directly or indirectly an interest
in the (underlying) issuer
Full chain of controlled undertakings through which the voting X
rights and/or the
financial instruments are effectively held starting with the
ultimate controlling natural person or legal entity (please
add additional rows as necessary)
Name % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is
is higher than instruments if higher than the
the notifiable it equals or is notifiable threshold
threshold higher than the
notifiable threshold
-------------------- ---------------------- ----------------------
John Dawson (beneficial
and non-beneficial
holdings) 3.5% 3.5%
-------------------- ---------------------- ----------------------
10. In case of proxy voting, please identify:
Name of the proxy holder N/A
----------------------------------------------
The number and % of voting rights N/A
held
----------------------------------------------
The date until which the voting N/A
rights will be held
----------------------------------------------
11. Additional information
N/A
Place of completion London, UK
Date of completion 01/06/2021
-----------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLFTMTTMTAMBIB
(END) Dow Jones Newswires
June 02, 2021 08:56 ET (12:56 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024
